About this Research Topic
The goal of the special issue in Frontiers in Surgery is to provide novel insights into the understanding of the immune-mediated pathophysiology of postoperative complications and adverse outcomes in surgical patients with COVID-19. There are multiple promising opportunities with candidate anti-inflammatory pharmacological agents that may help attenuate the increased postsurgical mortality observed in COVID-19 patients. Novel insights from clinical trials and pharmacological experimental research may provide a “bench-to-bedside” approach to attenuate the adverse outcomes after surgical procedures in COVID-19 patients.
All submissions will undergo a formal peer review by at least 2 qualified referees.
The scope of the special issue of the journal includes, but is not limited to, the following article types and areas of research:
- Basic experimental research in the immune pathophysiology of COVID-19;
- Investigation of novel therapeutic and pharmacological approaches to attenuate the hyperinflammatory response of COVID-19;
- Surgical techniques, indications, and patient selection algorithms to improve the outcomes in the vulnerable cohort of surgical COVID-19 patients;
- Case reports that describe unusual experiences and important lessons learned in the surgical care of COVID-19 patients;
- Review articles that cover pertinent areas of research described above.
Keywords: COVID-19, coronavirus disease, surgical complications, immune dysfunction, hyperinflammation, hypercoagulatibility, patient safety, risk stratification
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.